Biopharma financing during the fourth quarter of 2024 totaled $16.8bn from 251 deals. Of those, 60 reached $100m or more. The follow-on public offering (FOPO) and venture financing categories tied for
IN VITRO DIAGNOSTICS Biological Dynamics Inc. Biological Dynamics closes $26.8mm Series C round Molecular diagnostics firm Biological Dynamics Inc. raised $26.8mm through its Series C round (o
FDA will ask its Neurological Devices Panel to recommend appropriate follow-up timelines for clinical trials for stent-assisted coils and flow diverters when the experts meet April 17 at the agency's